Anna Berkenblit - 30 Dec 2022 Form 4 Insider Report for ImmunoGen, Inc.

Role
SVP & CHIEF MEDICAL OFFICER
Signature
/s/ Renee Lentini, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
30 Dec 2022
Net transactions value
+$1,709
Form type
4
Filing time
03 Jan 2023, 16:21:31 UTC
Previous filing
05 Jul 2022
Next filing
07 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Award $1,709 +436 +0.4% $3.92* 110,671 30 Dec 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from July 1, 2022 through December 31, 2022
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2022